Five years after the $1,000 genome introduction, the sequencing field remains rife with chatter about pushing the cost much lower. The race to drive sequencing costs ever lower may soon give way to a different kind of competition, in which companies one-up each other based on their ability to incorporate more powerful interpretive tools, support embedded applications, or tolerate adverse environments . . .